Directeur, Développement des affaires

About the role / À propos du rôleWe’re looking for a Business Development Director to join our Canada team. Reporting to the Vice President of Business Development – Canada, you will be responsible for driving the overall business development strategy within Canada, establishing Sygnature Discovery as the partner of choice for all discovery services. You will support and develop strategic partnerships to deliver high-value, high-quality, long-term collaborations with new and existing customers.Nous recherchons un Directeur du développement des affaires pour se joindre à notre équipe au Canada. Relevant du Vice-président du développement des affaires – Canada, vous serez responsable de la stratégie globale de développement des affaires au Canada, en établissant Sygnature Discovery comme le partenaire de choix pour tous les services de découverte. Vous soutiendrez et développerez des partenariats stratégiques pour offrir des collaborations à haute valeur ajoutée et à long terme.Key responsibilities / Responsabilités principalesSecure and retain business through professional, consultative and proactive activities directed at decision-makers and decision influencers in Biotech, Pharmaceutical and VC sectors.Interagir avec les responsables internes des opérations scientifiques, de la haute direction, du marketing et des domaines thérapeutiques pour soutenir la croissance et renforcer les relations clients.Position Sygnature as primary or preferred provider for all discovery services.Conduct market research and identify new business opportunities and projects.Identify leads, develop or maintain contact, and convert prospects into customers.Develop new business opportunities leveraging current service capabilities and internal resources to secure contracts that improve financial performance.Lead the sales cycle from interest to contract close for CRO services or strategic partnerships.Build a robust pipeline of high-quality, actionable opportunities to meet or exceed annual revenue targets.Stay informed about overall business trends within assigned market sectors.Network and represent the company at key events, conferences, and exhibitions.Qualifications / Compétences et qualificationsBachelor’s degree or equivalent in a scientific, business, or life sciences field.Significant experience in the drug discovery industry with a solid understanding of drug discovery and Sygnature’s value proposition.Proven success in a target-driven business development role in North America, ideally in Canada.Ability to create short- and long-term value through mutually beneficial relationships with new and existing clients.Strong analytical skills to read, analyse and interpret data and produce supporting reports.Demonstrated results achieving or exceeding commercial targets over multiple years.Excellent relationship-builder at all levels, internally and externally.Strong organisational skills and ability to work in a fast-moving, high-pressure environment.Benefits / AvantagesHealth and dental coverageDisability and life insurance3 weeks of vacationRegistered Retirement Plan with employer-matched contributionsTelemedicine programCasual dress codeFlexible schedulePersonal leaveOn-site parkingContinued education and professional developmentLocation & travel / Emplacement et déplacementsThe ideal candidate will be located in Canada’s major scientific hubs (Montréal, Toronto or Vancouver) with a valid driver’s license. The role will require up to 50% travel.Notes / RemarquesIf you have questions or would like more information, please contact the Talent Acquisition team at carrieres.ca@sygnaturediscovery.com. Do not send your application to this email address.Attention: this posting may close earlier than expected if there is high volume of applications. We encourage you to apply promptly.Background / ContexteSygnature Discovery is a world-leading integrated drug discovery Contract Research Organisation based in the UK and Canada with headquarters in Nottingham and additional facilities in Montreal and Quebec City, Alderley Park, Macclesfield, and Glasgow. Its staff of over 1,000 includes 900 scientists and collaborates with global pharma, biotech and NFP organisations.Since 2004, Sygnature Discovery has delivered over 61 novel pre-clinical compounds, including 38 clinical compounds, with over 170 patents. Therapeutic areas include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, and fibrotic diseases. For more information, visit www.sygnaturediscovery.com. #J-18808-Ljbffr